Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση του τοπικού αναισθητικού υδροχλωρικής λεβοβουπιβακαΐνης (levobupinacaine HCI) στον πηκτικό μηχανισμό

Abstract

dc:description

The ascertainment during the past 25 years that after the administration of local anaesthetics, except the interruption of painful conductance (analgesia), peripheral or central vasodilation occurs in the arterial as well as in the venous bed in addition to disturbances of the coagulation mechanism (e.g. lidocaine inhibits the platelet function and increases fibrinolysis), led to the investigation of these mechanisms and especially the behaviour of certain local anaesthetics (amides). This effect during the perioperative period may be beneficial as lower limb deep vein clotting formation is avoided. It may also be undesirable in case of intraoperative or postoperative haemorrhage. Therefore, the presence of an amide type local anaesthetic in the epidural space might: i. contribute to the therapeutic failure of an Epidural Blood Patch (EBP) which is often used for the management of an accidental Post Dural Puncture Headache (PDPH) in order to limit the further leakage of cerebrospinal fluid. ii. increase/worsen the haemorrhage due to accidental rupture of an epidural vein. The above mentioned conditions might induce ischaemia of the spinal cord. Levobupivacaine HCl or Chirocaine® is the newest amide type local anaesthetic used nowadays in clinical practice for epidural anaesthesia and analgesia. Till now, its effect on the coagulation mechanism in vivo has not been investigated. The scarce references concern in vitro or ex vivo approaches using thromboelastography. Technological revolution in the domain of molecular biology led to the use of the new susceptible molecular indicators for the investigation of coagulation [e.g. F1+2 prothrombin fragments, thrombin antithrombin complex (TAT)] and fibrinolysis [ddimers]. Therefore, the in vivo investigation of thrombotic or fibrinolytic situations due to the epidural administration of 0.75% levobupivacaine is an interesting research topic for the assessment of its effect on coagulation. The former mentioned investigation is the object/purpose of the present research clinico-laboratory study. The use of contemporary susceptible molecular indicators for the assessment of coagulation and fibrinolysis in in vivo situations makes this study original. The study is a clinico-laboratory one. The initial protocol outline included two (2) groups of adult volunteers: - Group A: Healthy adult volunteers (15) out of which 12 were enrolled as they complied to the protocol criteria (ASA - PS I). They received after informed consent 1.5 mg/kg b.w of 0.75% levobupivacaine i.m. in the vastus lateralis muscle of the lower limb. - Group B: Adult patients (43) out of which 31 were enrolled as they complied to the protocol criteria (ASA- PS I-II). They were administered after informed consent 1.5 mg/kg b.w 0.75% levobupivacaine epidurally and they underwent surgical hernia repair with the use of a plexus technique. Finally, all Group A volunteers, who were supposed to be the reference group in which the effect of levobupivacaine alone without any surgical stimulus was to be investigated, were excluded for the following reasons: a. The patients in Group B constitute per se their own reference during the control phase (C), i.e. during the phase of the effect of neither the anaesthetic nor the surgical factor. b. There was no reference of the i.m. use of levobupivacaine and therefore no knowledge about its pharmacokinetics and dosage. c. The number of volunteers was too small (n=12) in order to obtain specific and safe conclusions as to the effect of levobupivacaine on the coagulation when administered i.m. Therefore, the present study includes solely the patients in Group B who underwent surgical repair of their hernia. So, everything mentioned below is refered to the patients of Group B. All patients received premedication with per os diazepam according to body weight and age 45 min prior to epidural anaesthesia. An i.v. catheter was inserted in the upper limb for the administration of fluids and medication, whilst another one was inserted in the radial artery of the same limb for the invasive monitoring of blood pressure and blood samples. In all patients, except basic monitoring (E.C.G., H.R., SpO₂, ETCO₂ and NIBP), invasive BP measurement (BPS, BPD) was performed via the radial artery and withdrawal of blood samples were done for the measurement of the prothrombotic indicators (INR/PT, PTT, F1+2, TAT) and the fibrinolytic factor D – dimers. Haemodynamic measurements (HR, BPs, BPD and SpO₂) were done every 10, 20, 40, 60 min as well as during phases C, I, II, III when blood withdrawal was performed in order to estimate the reaction of the coagulation mechanism. Phase C = Control, without any intervention or drug administration. Phase I = 60΄ after epidural levobupivacaine administration prior to surgical incision. Phase II = 120΄ after epidural levobupivacaine administration and 60΄ post surgical incision. Phase III = 24 hours after epidural levobupivacaine administration. On each patient’s chart, time to anaesthetic block and its height at the corresponding dermotome was recorded every 10, 20, 40 and 60 min. At the same time any motor block was also recorded using the Bromage Scale. In order to detect or not any changes in the coagulation parameters, the susceptible molecular indicators were compared between phases and adverse reactions recorded. All patients with a history of coagulation disorders were excluded as well as those who received (within 7-10 days) drugs known for their effect on it. Except for usual laboratory tests (PT, INR and PTT ), the safe and specific assessment of coagulation was obtained by the determination of the changes in a) F1+2 prothrombin fragments b) TAT complex and c) fibrin degradation products (d-dimers). The levels of F1+2 prothrombin fragments were performed via immunoenzymatic assay (ELISA method) using monoclonic antibodies against F1+2 fragments. Likewise, TAT levels were performed via immunoenzymatic assay using monoclonic antibodies against TAT complex. Finally, the quantitative assay of plasma d-dimer was performed via immunoenzymatic assay using monoclonic antibodies against ddimers. During the first pilot calculations of the protocol, the power of the study was estimated. We focused on the limitation of the two basic errors of an experimental or clinical-laboratory trial. Type I Error was limited to a significance level a = 0.05. Type II Error was limited by the increase in the power of the study. Therefore, an a priori/ad hoc power analysis using the program G* power was performed. The study power for up to 30 patients in each Group A & B respectively, was 0.77 and the effect size = 0.25 with a confidence interval of at least a = 0.05. Patients’ demographics, in group B patients, were the following (mean ± SEM): N= 31, male(s) = 31, female(s) = 0, Age (years) = 56.45± 2.33, B.W.(kg) = 80.03 ± 2.37, Height (m) = 1.75 ± 0.01, ASA-PS: I = 13, II= 18 Statistical analysis of the patients’data who underwent surgery relative to the effect of levobupivacaine on coagulation was performed using SPSS 13.0 program for Windows (SPSS 13.0 , Chicago , IL). A Friedman’s non parametric test was performed as our data do not follow a normal distribution (Kolgomorov & Shapiro tests, p 0.05. - For F1+2 prothrombin fragments: Friedman’s test was statistically significant [x² (3, N=31) =16.12 p= 0.001]. Individual statistically significant intragroup differences were found with Bonferoni adjustment between phases C and II ( z= - 3.606, p<0.001 ) and phases I- II ( z = - 3.596, p<0.001 ). The non statistically significant intra-group differences between phases C and I show the lack of effect of levobupivacaine on coagulation as it is the sole factor that is present in phase I. The statistically significant differences between phases C-II and I-II disclose, with no doubt, the effect of the surgical stimulus on the mobilization of the coagulation mechanism as p<0.001]. Individual statistically significant intra-group differences (Bonferroni Adjustment) were found in phases C - III ( z= - 4.861, p<0.001 ) and I-III ( z= - 4.566, p<0.001 ) and II - II ( z= - 3.949, p<0.001 ). The statistically significant differences between phases C - III and I - III confirm, without any doubt, the surgical effect on the mobilization of the coagulation mechanism as p< 0.001. - Finally, for the TAT complex indicator, Friedman’s test was statistically significant [x² (3, N=31)=57.68, p<0.001]. Individual intra-group statistically significant differences (Wilcoxon paired test, Bonferroni Adjustment) were found between phases C - I ( z= -4.537, p<0.001), C - II ( z= -4.841, p<0.001), C - III ( z= -4.195, p<0.001), I - II ( z= -3.646, p<0.001), and II - III( z=-4.743, p<0.001). All comparisons were statistically significant (p<0.001) except between phases I - III. Initially, according to the results of our study, TAT complex indicator seems to be mobilized during phase I where the effect of the anaesthetic agent is anticipated . Its effect may seem controversial compared to F1+2 prothrombin fragments’ one and D-dimers’ one. Actually, this is not the case as TAT complex indicator is extremely susceptible and high values of it are anticipated and are attributed to the epidural anaesthesia technique or to the puncture of local blood vessels during epidural approach. As a conclusion, the results of the present study show that levobupivacaine administered epidurally does not seem to induce clinically significant changes in coagulation and fibrinolysis. The clinical significance of the results follows: 1. The presence of levobupivacaine in the epidural space does not seem to contribute to the therapeutic failure of an Autologous Epidural Blood Patch (AEBP) following the accidental puncture of the dura matter (beneficial effect) during: i. insertion of the Tuohy needle in the epidural space and ii. the shift of the epidural catheter which was placed for postoperative analgesia after which there is a significant leakage of CSF. Therapeutically 20 ml of autologous blood is injected in the epidural space in order to occlude the puncture. 2. The presence of levobupivacaine is unlikely to enhance haemorrhage (possible beneficial effect) when a blood vessel has been accidentally punctured in the epidural space and the risk of spinal cord ischemia is possible due to the pressure effect of the haematoma in the epidural space. 3. On the other hand, the non effect of levobupivacaine on the coagulation mechanism, during the perioperative period, does not seem beneficial so as to avoid deep vein thrombosis of the lower limbs and the likelihood of pulmonary embolism after major abdominal and lower limb interventions that require long term immobilization.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Βαγάνωφ, Ευμορφία
  • Vaganof, Evmorfia

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19540

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Βαγάνωφ, Ευμορφία; Vaganof, Evmorfia. Η επίδραση του τοπικού αναισθητικού υδροχλωρικής λεβοβουπιβακαΐνης (levobupinacaine HCI) στον πηκτικό μηχανισμό. Aristotle University Of Thessaloniki (AUTH), 2008. http://hdl.handle.net/10442/hedi/19540